<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33901988</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>102674</StartPage><MedlinePgn>102674</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102674</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2021.102674</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(21)00118-2</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that is characterized by a high heterogeneity in patients' disease course. Patients with bulbar onset of symptoms (b-ALS) have a poorer prognosis than patients with limb onset (l-ALS). However, neuroimaging correlates of the assumed biological difference between b-ALS and l-ALS may have been obfuscated by patients' diversity in the disease course. We conducted Voxel-Based-Morphometry (VBM) and Tract-Based-Spatial-Statistics (TBSS) in a group of 76 ALS patients without clinically relevant cognitive deficits. The subgroups of 26 b-ALS and 52&#xa0;l-ALS patients did not differ in terms of disease Phase or disease aggressiveness according to the D50 progression model. VBM analyses showed widespread ALS-related changes in grey and white matter, that were more pronounced for b-ALS. TBSS analyses revealed that b-ALS was predominantly characterized by frontal fractional anisotropy decreases. This demonstrates a higher degree of neurodegenerative burden for the group of b-ALS patients in comparison to l-ALS. Correspondingly, higher bulbar symptom burden was associated with right-temporal and inferior-frontal grey matter density decreases as well as fractional anisotropy decreases in inter-hemispheric and long association tracts. Contrasts between patients in Phase I and Phase II further revealed that b-ALS was characterized by an early cortical pathology and showed a spread only outside primary motor regions to frontal and temporal areas. In contrast, l-ALS showed ongoing structural integrity loss within primary motor-regions until Phase II. We therefore provide a strong rationale to treat both onset types of disease separately in ALS studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Steinbach</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany. Electronic address: Robert.Steinbach@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prell</LastName><ForeName>Tino</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaur</LastName><ForeName>Nayana</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roediger</LastName><ForeName>Annekathrin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaser</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witte</LastName><ForeName>Otto W</ForeName><Initials>OW</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosskreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany; Center for Healthy Ageing, Jena University Hospital, Jena.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="Y">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Bulbar-onset</Keyword><Keyword MajorTopicYN="N">D50 model</Keyword><Keyword MajorTopicYN="N">Limb-onset</Keyword><Keyword MajorTopicYN="N">Tract&#x2013;based spatial statistics</Keyword><Keyword MajorTopicYN="N">Voxel-based morphometry</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>26</Day><Hour>20</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33901988</ArticleId><ArticleId IdType="pmc">PMC8099783</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2021.102674</ArticleId><ArticleId IdType="pii">S2213-1582(21)00118-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrahams S., Newton J., Niven E., Foley J., Bak T.H. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Pagani E., Rocca M.A., Caputo D., Perini M., Salvi F., Prelle A., Filippi M. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp. 2007;28:1430&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871473</ArticleId><ArticleId IdType="pubmed">17370339</ArticleId></ArticleIdList></Reference><Reference><Citation>Alruwaili A.R., Pannek K., Coulthard A., Henderson R., Kurniawan N.D., McCombe P. A combined tract-based spatial statistics and voxel-based morphometry study of the first MRI scan after diagnosis of amyotrophic lateral sclerosis with subgroup analysis. J Neuroradiol. 2018;45:41&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">28802959</ArticleId></ArticleIdList></Reference><Reference><Citation>Appollonio I., Leone M., Isella V., Piamarta F., Consoli T., Villa M.L., Forapani E., Russo A., Nichelli P. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005;26:108&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">15995827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A., Elamin M., Byrne S., McLaughlin R.L., Jordan N., Hampel H., Gallagher L., Lynch C., Fagan A.J., Pender N., Hardiman O. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry. 2013;84:766&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">23085933</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsodi F., Culea V., Langkammer C., Khalil M., Pirpamer L., Quasthoff S., Enzinger C., Schmidt R., Fazekas F., Ropele S. Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis. PloS one. 2017;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5456080</ArticleId><ArticleId IdType="pubmed">28575122</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis&#x2013;a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9:708&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks, B.R., Miller, R.G., Swash, M., Munsat, T.L., of on Diseases, W., 2000. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 1, 293-299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A., Moglia C., Lunetta C., Marinou K., Ticozzi N., Ferrante G.D., Scialo C., Soraru G., Trojsi F., Conte A., Falzone Y.M., Tortelli R., Russo M., Chio A., Sansone V.A., Mora G., Silani V., Volanti P., Caponnetto C., Querin G., Monsurro M.R., Sabatelli M., Riva N., Logroscino G., Messina S., Fini N., Mandrioli J. Factors predicting survival in ALS: a multicenter Italian study. J Neurol. 2017;264:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Blanco A., Machts J., Acosta-Cabronero J., Kaufmann J., Abdulla S., Kollewe K., Petri S., Heinze H.J., Dengler R., Vielhaber S., Nestor P.J. Central white matter degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis. J Neurol. 2014;261:1961&#x2013;1967.</Citation><ArticleIdList><ArticleId IdType="pubmed">25059391</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Hammond E.R., Mora G., Bonito V., Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirillo M., Esposito F., Tedeschi G., Caiazzo G., Sagnelli A., Piccirillo G., Conforti R., Tortora F., Monsurro M.R., Cirillo S., Trojsi F. Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study. AJNR Am J Neuroradiol. 2012;33:1102&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013257</ArticleId><ArticleId IdType="pubmed">22300932</ArticleId></ArticleIdList></Reference><Reference><Citation>Creavin, S.T., Wisniewski, S., Noel-Storr, A.H., Trevelyan, C.M., Hampton, T., Rayment, D., Thom, V.M., Nash, K.J., Elhamoui, H., Milligan, R., Patel, A.S., Tsivos, D.V., Wing, T., Phillips, E., Kellman, S.M., Shackleton, H.L., Singleton, G.F., Neale, B.E., Watton, M.E., Cullum, S., 2016. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev, CD011145.</Citation><ArticleIdList><ArticleId IdType="pubmed">26760674</ArticleId></ArticleIdList></Reference><Reference><Citation>de Albuquerque M., Branco L.M., Rezende T.J., de Andrade H.M., Nucci A., Franca M.C., Jr. Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis. Neuroimage Clin. 2017;14:269&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5294732</ArticleId><ArticleId IdType="pubmed">28203530</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine M.S., Farrell A., Woodhouse H., McCombe P.A., Henderson R.D. A developmental perspective on bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:638&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pubmed">23859502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55:1621&#x2013;1626.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113214</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A. Amyotrophic lateral sclerosis-Evolutionary and other perspectives. Muscle Nerve. 2009;40:297&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">19609920</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Braak H., Del Tredici K., Lemon R., Ludolph A.C., Kiernan M.C. Cortical influences drive amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:917&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan L., Li H., Zhuo J., Zhang Y., Wang J., Chen L., Yang Z., Chu C., Xie S., Laird A.R., Fox P.T., Eickhoff S.B., Yu C., Jiang T. The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture. Cereb Cortex. 2016;26:3508&#x2013;3526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4961028</ArticleId><ArticleId IdType="pubmed">27230218</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter M.K., Danielian L.E., Braun L.E., Wu T. Longitudinal diffusion imaging across the C9orf72 clinical spectrum. J Neurol Neurosurg Psychiatry. 2018;89:53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454927</ArticleId><ArticleId IdType="pubmed">29054917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesalingam J., Stahl D., Wijesekera L., Galtrey C., Shaw C.E., Leigh P.N., Al-Chalabi A. Latent cluster analysis of ALS phenotypes identifies prognostically differing groups. PloS one. 2009;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2741575</ArticleId><ArticleId IdType="pubmed">19771164</ArticleId></ArticleIdList></Reference><Reference><Citation>Genon S., Reid A., Li H., Fan L., Muller V.I., Cieslik E.C., Hoffstaedter F., Langner R., Grefkes C., Laird A.R., Fox P.T., Jiang T., Amunts K., Eickhoff S.B. The heterogeneity of the left dorsal premotor cortex evidenced by multimodal connectivity-based parcellation and functional characterization. Neuroimage. 2018;170:400&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5555826</ArticleId><ArticleId IdType="pubmed">28213119</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenlee J.D., Oya H., Kawasaki H., Volkov I.O., Kaufman O.P., Kovach C., Howard M.A., Brugge J.F. A functional connection between inferior frontal gyrus and orofacial motor cortex in human. J Neurophysiol. 2004;92:1153&#x2013;1164.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056683</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung V., Prell T., Gaser C., Turner M.R., Tietz F., Ilse B., Bokemeyer M., Witte O.W., Grosskreutz J. Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis. PloS one. 2014;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136773</ArticleId><ArticleId IdType="pubmed">25133577</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Hu F., Zhang Q., Chen Q., Li H., Qin X., Jia R., Kang L., Dang Y., Dang J. Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis. Sci Rep. 2019;9:20059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6934517</ArticleId><ArticleId IdType="pubmed">31882886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J., Unrath A., Huppertz H.J., Lule D., Ethofer T., Sperfeld A.D., Ludolph A.C. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:213&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">16319024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., de Leon M., Wang X., Kim H.Y., Lee Y.J., Kim Y.H., Kim S.H. Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study. PloS one. 2017;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5240978</ArticleId><ArticleId IdType="pubmed">28095425</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Marin B., Piccininni M., Arcuti S., Chio A., Hardiman O., Rooney J., Zoccolella S., Couratier P., Preux P.M., Beghi E., for, E Referral bias in ALS epidemiological studies. PloS one. 2018;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901916</ArticleId><ArticleId IdType="pubmed">29659621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule D., Burkhardt C., Abdulla S., Bohm S., Kollewe K., Uttner I., Abrahams S., Bak T.H., Petri S., Weber M., Ludolph A.C. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25292386</ArticleId></ArticleIdList></Reference><Reference><Citation>Morecraft R.J., Stilwell-Morecraft K.S., Rossing W.R. The motor cortex and facial expression: new insights from neuroscience. Neurologist. 2004;10:235&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">15335441</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., De Schaepdryver M., Stubendorff B., Gille B., Muckova P., Wendler S., Prell T., Ringer T.M., Rhode H., Stevens O., Claeys K.G., Couwelier G., D'Hondt A., Lamaire N., Tilkin P., Van Reijen D., Gourmaud S., Fedtke N., Heiling B., Rumpel M., Rodiger A., Gunkel A., Witte O.W., Paquet C., Vandenberghe R., Grosskreutz J., Van Damme P. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. 2017;88:2302&#x2013;2309.</Citation><ArticleIdList><ArticleId IdType="pubmed">28500227</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Gaur N., Steinbach R., Witte O.W., Grosskreutz J. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data. Health Qual Life Outcomes. 2020;18:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195704</ArticleId><ArticleId IdType="pubmed">32357946</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Peschel T., Hartung V., Kaufmann J., Klauschies R., Bodammer N., Kollewe K., Dengler R., Grosskreutz J. Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2013;115:1281&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pubmed">23266262</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudlo J., Bissbort C., Glass A., Grossmann A., Hauenstein K., Benecke R., Teipel S.J. White matter pathology in ALS and lower motor neuron ALS variants: a diffusion tensor imaging study using tract-based spatial statistics. J Neurol. 2012;259:1848&#x2013;1859.</Citation><ArticleIdList><ArticleId IdType="pubmed">22349938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V., Pioro E.P. Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:216&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">24555884</ArticleId></ArticleIdList></Reference><Reference><Citation>Roccatagliata L., Bonzano L., Mancardi G., Canepa C., Caponnetto C. Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">18622772</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche J.C., Rojas-Garcia R., Scott K.M., Scotton W., Ellis C.E., Burman R., Wijesekera L., Turner M.R., Leigh P.N., Shaw C.E., Al-Chalabi A. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage C.A., Van Hecke W., Peeters R., Sijbers J., Robberecht W., Parizel P., Marchal G., Leemans A., Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp. 2009;30:3657&#x2013;3675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6870610</ArticleId><ArticleId IdType="pubmed">19404990</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Kasper E., Machts J., Bittner D., Kaufmann J., Benecke R., Teipel S., Vielhaber S., Prudlo J. Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J Neurol. 2013;260:2856&#x2013;2864.</Citation><ArticleIdList><ArticleId IdType="pubmed">23996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellikeri S., Myers M., Black S.E., Abrahao A., Zinman L., Yunusova Y. Speech network regional involvement in bulbar ALS: a multimodal structural MRI study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:385&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6648678</ArticleId><ArticleId IdType="pubmed">31088163</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N.G., Turner M.R., Vucic S., Al-Chalabi A., Shefner J., Lomen-Hoerth C., Kiernan M.C. Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol. 2014;76:643&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4305209</ArticleId><ArticleId IdType="pubmed">25223628</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44:83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage. 2002;17:1429&#x2013;1436.</Citation><ArticleIdList><ArticleId IdType="pubmed">12414282</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson E.J., Mandrekar J., Crum B., Stevens J.C. Effect of referral bias on assessing survival in ALS. Neurology. 2007;68:600&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">17310031</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Batyrbekova M., Gaur N., Voss A., Stubendorff B., Mayer T.E., Gaser C., Witte O.W., Prell T., Grosskreutz J. Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6940701</ArticleId><ArticleId IdType="pubmed">31896467</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Gaur N., Roediger A., Mayer T.E., Witte O.W., Prell T., Grosskreutz J. Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Hum Brain Mapp. 2021;42:737&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814763</ArticleId><ArticleId IdType="pubmed">33103324</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Prell T., Gaur N., Stubendorff B., Roediger A., Ilse B., Witte O.W., Grosskreutz J. Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model. J Clin Med. 2020;9:2873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7565659</ArticleId><ArticleId IdType="pubmed">32899481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuno H., Takada M., Nambu A., Inase M. Reevaluation of ipsilateral corticocortical inputs to the orofacial region of the primary motor cortex in the macaque monkey. J Comp Neurol. 1997;389:34&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">9390758</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F., Caiazzo G., Corbo D., Piccirillo G., Cristillo V., Femiano C., Ferrantino T., Cirillo M., Monsurro M.R., Esposito F., Tedeschi G. Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis. PloS one. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4368555</ArticleId><ArticleId IdType="pubmed">25793718</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F., Siciliano M., Femiano C., Santangelo G., Lunetta C., Calvo A., Moglia C., Marinou K., Ticozzi N., Drago Ferrante G., Scialo C., Soraru G., Conte A., Falzone Y.M., Tortelli R., Russo M., Sansone V.A., Chio A., Mora G., Poletti B., Volanti P., Caponnetto C., Querin G., Sabatelli M., Riva N., Logroscino G., Messina S., Fasano A., Monsurro M.R., Tedeschi G., Mandrioli J. Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort. J Neurol. 2017;264:2224&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pubmed">28914354</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Hammers A., Allsop J., Al-Chalabi A., Shaw C.E., Brooks D.J., Leigh P.N., Andersen P.M. Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:343&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">18033592</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh H.K., Westeneng H.J., Walhout R., van Veenhuijzen K., Tan H.H.G., Meier J.M., Bakker L.A., Hendrikse J., van Es M.A., Veldink J.H., van den Heuvel M.P., van den Berg L.H. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology. 2020</Citation></Reference><Reference><Citation>van der Graaff M.M., Sage C.A., Caan M.W., Akkerman E.M., Lavini C., Majoie C.B., Nederveen A.J., Zwinderman A.H., Vos F., Brugman F., van den Berg L.H., de Rijk M.C., van Doorn P.A., Van Hecke W., Peeters R.R., Robberecht W., Sunaert S., de Visser M. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain. 2011;134:1211&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pubmed">21362631</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete, E., Turner, M.R., Grosskreutz, J., Filippi, M., Benatar, M., attendees of the 4th Ni, S.m., 2015. Mind the gap: the mismatch between clinical and imaging metrics in ALS. Amyotroph Lateral Scler Frontotemporal Degener 16, 524-529.</Citation><ArticleIdList><ArticleId IdType="pubmed">26402254</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.J., Debray T.P.A., Visser A.E., van Eijk R.P.A., Rooney J.P.K., Calvo A., Martin S., McDermott C.J., Thompson A.G., Pinto S., Kobeleva X., Rosenbohm A., Stubendorff B., Sommer H., Middelkoop B.M., Dekker A.M., van Vugt J., van Rheenen W., Vajda A., Heverin M., Kazoka M., Hollinger H., Gromicho M., Korner S., Ringer T.M., Rodiger A., Gunkel A., Shaw C.E., Bredenoord A.L., van Es M.A., Corcia P., Couratier P., Weber M., Grosskreutz J., Ludolph A.C., Petri S., de Carvalho M., Van Damme P., Talbot K., Turner M.R., Shaw P.J., Al-Chalabi A., Chio A., Hardiman O., Moons K.G.M., Veldink J.H., van den Berg L.H. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler A.M., Ridgway G.R., Webster M.A., Smith S.M., Nichols T.E. Permutation inference for the general linear model. Neuroimage. 2014;92:381&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010955</ArticleId><ArticleId IdType="pubmed">24530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Chen G., He M., Dai J., Shang H., Gong Q., Jia Z. Altered white matter microarchitecture in amyotrophic lateral sclerosis: A voxel-based meta-analysis of diffusion tensor imaging. Neuroimage Clin. 2018;19:122&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051469</ArticleId><ArticleId IdType="pubmed">30035009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Ji B., Hu J., Zhou C., Li L., Li Z., Huang X., Hu X. Aberrant interhemispheric homotopic functional and structural connectivity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:369&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">27913627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>